or
Bookmark and Share
Methods for rendering amplified nucleic acid subsequently unamplifiable
   
Document Number
US Patent 5221608
Issued Date
June 22, 1993
Link
Map
Abstract
Method for treating nucleic acid that is to be amplified such that the nucleic acid is, after amplification, subsequently unamplifiable. Nucleic acid amplification is performed in a reaction containing means in the presence of an isopsoralen. The reaction is thereafter irradiated to render the amplified nucleic acid substantially unamplifiable.
Drawing
Methods for rendering amplified nucleic acid subsequently unamplifiable - US Patent 5221608 Drawing
Drawing from US Patent 5221608
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
3
Comments:
no comments yet
Owner
Published
June 22, 1993
Application Number
07/428,494
Filed
October 26, 1989
US Classification
435/6   435/808 435/91.2 435/92 436/501 436/805 514/455 536/22.1 536/23.1
Int'l Classification
C07D   493/04   (20060101)   C07D   493/00   (20060101)   C12P   19/00   (20060101)   C12P   19/34   (20060101)   C12Q   1/68   (20060101)   B01L   7/00   (20060101)   C07D   311/18   (20060101)   C07D   519/00   (20060101)   C07D   311/00   (20060101)   C07H   21/00   (20060101)   C12Q   1/70   (20060101)   C12N   15/10   (20060101)  
Assistant Examiner
Attorney/Law Firm
USPTO Field of Search
435/6   435/91   435/808   436/501   436/805   536/26   536/27   536/28   536/29   514/455   935/17   935/78   935/88  
Related Patents
5589339 - Subtraction hybridization - Owned by Amersham International PLC (Bucks,GB)

A novel process is disclosed utilizing a subtraction hybridization technique for producing DNA hybridization probes of high specific activity or cDNA subtraction libraries, useful in connection with the cloning of differentially expressed genes. A preparation of single stranded cDNA derived from transcript mRNA of a target cell source is subjected to subtraction hybridization using excess single stranded "driver" nucleic acid from a reference cell source so that all the cDNA having a nucleotide sequence complementary to transcript mRNA of the reference cell source is subtracted by annealing with the "driver" nucleic acid to form duplex molecules. The strands of these duplex molecules are then chemically cross-linked by treatment with an aziridinylbenzoquinone interstrand cross-linking agent, and the remaining unsubtracted single stranded unique cDNA derived solely from the target cell source is processed in the presence of the chemically cross-linked duplex molecules to provide labelled probe material or a subtraction cDNA library, using random priming and a DNA polymerase lacking exonuclease activity and inactive with respect to the cross-linked duplex molecules.

5705332 - Detection and identification of Salmonella and Shigella - Owned by University of Hawaii (Honolulu, HI)

The present invention is directed to methods and reagents for the specific detection and presumptive identification of various bacteria associated with waterborne infectious disease. In particular, this invention relates to methods and reagents for the specific detection and identification of Salmonella and Shigella in environmental samples such as water and sewage.

5627275 - Detection and identification of enteric pathogens - Owned by University of Hawaii (Honolulu, HI)

The present invention is directed to methods and reagents for the specific detection and presumptive identification of various bacteria associated with waterborne infectious disease. In particular, this invention relates to methods and reagents for the specific detection and identification of Salmonella and Shigella in environmental samples such as water and sewage.

5763186 - Use of antisense oligomers in a process for controlling contamination in nucleic acid amplification reactions - Owned by Chiron Diagnostics Corporation (East Walpole, MA)

A novel process for the use of antisense oligonucleotides and analogs thereof has been developed. Namely, this technique is useful for the elimination of contamination in the nucleic acid amplification area. Elimination of unwanted contamination has made gene probe analyses much more reproduceable.

5372929 - Methods for measuring the inactivation of pathogens

Methods for measuring pathogen inactivation, and in particular, methods for measuring pathogen inactivation in blood and blood products after photochemical decontamination. The methods involve measuring the inhibition of template-dependent enzymatic synthesis of nucleic acid following the addition of compounds that add covalently to nucleic acid.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us